Microarray analysis of lncRNAs and mRNAs co-expression network and lncRNA function as cerna in papillary thyroid carcinoma

Journal of Biomaterials and Tissue Engineering

Volumn 5, Issue 11, 2015, Pages 872-880

  Xie, Jing ^a   Guo, Bomin ^a   Ding, Zheng ^a   Kang, Jie ^a   Deng, Xianzhao ^a   Wu, Bo ^a   Fan, Youben ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

CeRNA; lncRNA; Microarray; mRNA; Papillary thyroid carcinoma

Indexed keywords

COMPETING ENDOGENOUS RNA; LONG UNTRANSLATED RNA; MESSENGER RNA; RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BIOINFORMATICS; CLINICAL ARTICLE; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE ONTOLOGY; GENE REGULATORY NETWORK; HUMAN; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; THYROID CARCINOMA; ULTRAVIOLET SPECTROPHOTOMETRY; UPREGULATION; YOUNG ADULT;

EID: 84951289069     PISSN: 21579083     EISSN: 21579091     Source Type: Journal    
DOI: 10.1166/jbt.2015.1389     Document Type: Article

References (34)

1. M. A. Rosenbaum and C. R. McHenry, Contemporary management of papillary carcinoma of the thyroid gland. Expert. Rev. Anticancer Ther. 9, 317 (2009).
2. T. J. O'Grady, M. A. Gates, and F. P. Boscoe, Thyroid cancer incidence attributable to overdiagnosis in the United States 1981-2011. Int. J. Cancer 137, 2664 (2015).
3. L. G. Morris, A. G. Sikora, T. D. Tosteson, and L. Davies, The increasing incidence of thyroid cancer: The influence of access to care. Thyroid 23, 885 (2013).
4. P. Marques, V. Leite, and M. J. Bugalho, Retrospective analysis of 255 papillary thyroid carcinomas
5. P. Siironen, J. Louhimo, S. Nordling, A. Ristimaki, H. Maenpaa, R. Haapiainen, and C. Haglund, Prognostic factors in papillary thyroid cancer: An evaluation of 601 consecutive patients. Tumour Biol. 26, 57 (2005).
6. S. Young, A. Harari, S. Smooke-Praw, P. H. Ituarte, and M. W. Yeh, Effect of reoperation on outcomes in papillary thyroid cancer. Surgery 154, 1354, discussion 1361-2 (2013).
7. X. Li and Z. Wang, The role of noncoding RNA in thyroid cancer. Gland Surg. 1, 146 (2012).
8. X. Lan, H. Zhang, Z. Wang, W. Dong, W. Sun, L. Shao, T. Zhang, and D. Zhang, Genome-wide analysis of long noncoding RNA expression profile in papillary thyroid carcinoma. Gene 569, 109 (2015).
9. J. Liz and M. Esteller, lncRNAs and microRNAs with a role in cancer development. Biochim. Biophys. Acta (2015), in press.
10. X. Shi, M. Sun, H. Liu, Y. Yao, and Y. Song, Long non-coding RNAs: A new frontier in the study of human diseases. Cancer Lett. 339, 159 (2013).
11. P. Johnsson, L. Lipovich, D. Grander, and K. V. Morris, Evolutionary conservation of long non-coding RNAs; sequence, structure, function. Biochim. Biophys. Acta 1840, 1063 (2014).
12. A. E. Kornienko, P. M. Guenzl, D. P. Barlow, and F. M. Pauler, Gene regulation by the act of long non-coding RNA transcription. BMC Biol. 11, 59 (2013).
13. Q. Liao, C. Liu, X. Yuan, S. Kang, R. Miao, H. Xiao, G. Zhao, H. Luo, D. Bu, H. Zhao, G. Skogerbo, Z. Wu, and Y. Zhao, Largescale prediction of long non-coding RNA functions in a coding-noncoding gene co-expression network. Nucleic. Acids Res. 39, 3864 (2011).
14. R. Sen, S. Ghosal, S. Das, S. Balti, and J. Chakrabarti, Competing endogenous RNA: The key to posttranscriptional regulation. Scientific World Journal 2014, 896206 (2014).
15. D. Han, M. Wang, N. Ma, Y. Xu, Y. Jiang, and X. Gao, Long noncoding RNAs: Novel players in colorectal cancer. Cancer Lett. 361, 13 (2015).
16. A. C. Tahira, M. S. Kubrusly, M. F. Faria, B. Dazzani, R. S. Fonseca, V. Maracaja-Coutinho, S. Verjovski-Almeida, M. C. Machado, and E. M. Reis, Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer. Mol. Cancer 10, 141 (2011).
17. Z. Zhao, Y. Song, D. Piao, T. Liu, and L. Zhao, Identification of genes and long non-coding RNAs associated with the pathogenesis of gastric cancer. Oncol. Rep. (2015), in press.
18. C. Li, J. Chen, K. Zhang, B. Feng, R. Wang, and L. Chen, Progress and prospects of long noncoding RNAs (lncRNAs) in hepatocellular carcinoma. Cell Physiol. Biochem. 36, 423 (2015).
19. S. Zeng, Y. F. Xiao, B. Tang, C. J. Hu, R. Xie, S. M. Yang, and B. S. Li, Long noncoding RNA in digestive tract cancers: Function, mechanism, and potential biomarker. Oncologist 20, 898 (2015).
20. Y. Wang, Q. Guo, Y. Zhao, J. Chen, S. Wang, J. Hu, and Y. Sun, BRAF-activated long non-coding RNA contributes to cell proliferation and activates autophagy in papillary thyroid carcinoma. Oncol. Lett. 8, 1947 (2014).
21. H. Yoon, H. He, R. Nagy, R. Davuluri, S. Suster, D. Schoenberg, N. Pellegata, and L. C. Ade, Identification of a novel noncoding RNA gene, NAMA, that is downregulated in papillary thyroid carcinoma with BRAF mutation and associated with growth arrest. Int. J. Cancer 121, 767 (2007).
22. G. Yu, L. G. Wang, Y. Han, and Q. Y. He, clusterProfiler: An R package for comparing biological themes among gene clusters. OMICS 16, 284 (2012).
23. J. H. Li, S. Liu, H. Zhou, L. H. Qu, and J. H. Yang, starBase v 2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic. Acids Res. 42(Database issue), D92 (2014).
24. P. Shannon, A. Markiel, O. Ozier, N. S. Baliga, J. T. Wang, D. Ramage, N. Amin, B. Schwikowski, and T. Ideker, Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498 (2003).
25. H. He, W. Li, S. Liyanarachchi, J. Jendrzejewski, M. Srinivas, R. V. Davuluri, R. Nagy, and A. de la Chapelle, Genetic predisposition to papillary thyroid carcinoma: Involvement of FOXE1, TSHR, and a novel lincRNA gene, PTCSC2. J. Clin. Endocrinol. Metab 100, E164 (2015).
26. J. Jendrzejewski, H. He, H. S. Radomska, W. Li, J. Tomsic, S. Liyanarachchi, R. V. Davuluri, R. Nagy, and A. de la Chapelle, The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type. Proc. Natl. Acad. Sci. U. S. A. 109, 8646 (2012).
27. M. Fan, X. Li, W. Jiang, Y. Huang, J. Li, and Z. Wang, A long non-coding RNA, PTCSC3, as a tumor suppressor and a target of miRNAs in thyroid cancer cells. Exp. Ther. Med. 5, 1143 (2013).
28. H. S. Kim, H. Kim do, J. Y. Kim, N. H. Jeoung, I. K. Lee, J. G. Bong, and E. D. Jung, Microarray analysis of papillary thyroid cancers in Korean. Korean J. Intern. Med. 25, 399 (2010).
29. K. W. Chung and S. W. Kim, Gene expression profiling of papillary thyroid carcinomas in Korean patients by oligonucleotide microarrays. J. Korean Surg. Soc. 82, 271 (2012).
30. R. Dong, D. Jia, P. Xue, X. Cui, K. Li, S. Zheng, X. He, and K. Dong, Genome-wide analysis of long noncoding RNA (lncRNA) expression in hepatoblastoma tissues. PLoS One 9, e85599 (2014).
31. Z. Liu, X. Li, N. Sun, Y. Xu, Y. Meng, C. Yang, Y. Wang, and K. Zhang, Microarray profiling and co-expression network analysis of circulating lncRNAs and mRNAs associated with major depressive disorder. PLoS One 9, e93388 (2014).
32. T. Xia, Q. Liao, X. Jiang, Y. Shao, B. Xiao, Y. Xi, and J. Guo, Long noncoding RNA associated-competing endogenous RNAs in gastric cancer. Sci. Rep. 4, 6088 (2014).
33. P. Paci, T. Colombo, and L. Farina, Computational analysis identifies a sponge interaction network between long non-coding RNAs and messenger RNAs in human breast cancer. BMC Syst. Biol. 8, 83 (2014).
34. X. Song, G. Cao, L. Jing, S. Lin, X. Wang, J. Zhang, M. Wang, W. Liu, and C. Lv, Analysing the relationship between lncRNA and protein-coding gene and the role of lncRNA as ceRNA in pulmonary fibrosis. J. Cell Mol. Med. 18, 991 (2014).